COMPENSATION OF EXECUTIVEOFFICERS OF NITROMED, INC.
Exhibit 10.1
COMPENSATION OF EXECUTIVE OFFICERS OF NITROMED, INC.
As of January 19, 2006, the following sets forth the compensation of the executive officers of NitroMed, Inc.:
EXECUTIVE OFFICER |
| 2006 ANNUAL |
| 2005 BONUS |
| ||
|
|
|
|
|
| ||
Michael D. Loberg, Ph.D. |
| $ | 361,328 |
| $ | 85,000 |
|
|
|
|
|
|
| ||
Manuel Worcel, M.D.(1) |
| $ | |
| $ | 49,000 |
|
|
|
|
|
|
| ||
L. Gordon Letts, Ph.D. |
| $ | 270,218 |
| $ | 45,400 |
|
|
|
|
|
|
| ||
Lawrence E. Bloch, M.D., J.D. |
| $ | 279,734 |
| $ | 67,173 |
|
|
|
|
|
|
| ||
Mark H. Pavao |
| $ | 265,850 |
| $ | 54,320 |
|
|
|
|
|
|
| ||
Lisa Kelly(2) |
| $ | 210,700 |
| $ | |
|
|
|
|
|
|
| ||
Michael L. Sabolinski(3) |
| $ | 270,105 |
| $ | |
|
|
|
|
|
|
| ||
Jane Kramer |
| $ | 212,800 |
| $ | 12,250 |
|
(1) Dr. Worcel ceased to serve as an executive officer of NitroMed on January 5, 2006.
(2) Ms. Kelly became an executive officer of NitroMed on January 6, 2006.
(3) Mr. Sabolinski became an executive officer of NitroMed on January 6, 2006.
In addition, each of NitroMed, Inc.s executive officers is eligible to participate in NitroMeds 2003 Amended and Restated Stock Incentive Plan and any successor plan.